Christopher Anzalone,
PhD

• President, CEO, Director, and Chairman of the Board of Arrowhead Pharmaceuticals since 2007

• Founder and former CEO of Benet Group LLC, a private equity firm focused on building nano-biotechnology companies from university-generated science

• Former partner at Galway Partners, where he sourced, structured, and built new business ventures

• Ph.D. in Biology from UCLA; B.A. in Government from Lawrence University